167 related articles for article (PubMed ID: 35565203)
1. Overexpression of GATA5 Inhibits Prostate Cancer Progression by Regulating PLAGL2 via the FAK/PI3K/AKT Pathway.
Wang Q; Liu Z; Zhai G; Yu X; Ke S; Shao H; Guo J
Cancers (Basel); 2022 Apr; 14(9):. PubMed ID: 35565203
[TBL] [Abstract][Full Text] [Related]
2. FAM107A Inactivation Associated with Promoter Methylation Affects Prostate Cancer Progression through the FAK/PI3K/AKT Pathway.
Ke S; Liu Z; Wang Q; Zhai G; Shao H; Yu X; Guo J
Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010909
[TBL] [Abstract][Full Text] [Related]
3. GATA binding protein 5-mediated transcriptional activation of transmembrane protein 100 suppresses cell proliferation, migration and epithelial-to-mesenchymal transition in prostate cancer DU145 cells.
Liu J; Lin F; Wang X; Li C; Qi Q
Bioengineered; 2022 Apr; 13(4):7972-7983. PubMed ID: 35358005
[TBL] [Abstract][Full Text] [Related]
4. Effect of transmembrane protein 100 on prostate cancer progression by regulating SCNN1D through the FAK/PI3K/AKT pathway.
Ye Z; Xia Y; Li L; Li B; Chen W; Han S; Zhou X; Chen L; Yu W; Ruan Y; Cheng F
Transl Oncol; 2023 Jan; 27():101578. PubMed ID: 36375375
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of Pleomorphic Adenoma Gene-Like 2 Is a Novel Poor Prognostic Marker of Prostate Cancer.
Guo J; Wang M; Wang Z; Liu X
PLoS One; 2016; 11(8):e0158667. PubMed ID: 27537362
[TBL] [Abstract][Full Text] [Related]
6. Long non-coding RNA MAPKAPK5-AS1/PLAGL2/HIF-1α signaling loop promotes hepatocellular carcinoma progression.
Wang L; Sun L; Liu R; Mo H; Niu Y; Chen T; Wang Y; Han S; Tu K; Liu Q
J Exp Clin Cancer Res; 2021 Feb; 40(1):72. PubMed ID: 33596983
[TBL] [Abstract][Full Text] [Related]
7. CMTM5 inhibits the development of prostate cancer via the EGFR/PI3K/AKT signaling pathway.
Li L; Hu Y; Chen D; Zhu J; Bao W; Xu X; Chen H; Chen W; Feng R
Mol Med Rep; 2022 Jan; 25(1):. PubMed ID: 34791506
[TBL] [Abstract][Full Text] [Related]
8.
Xiao ZM; Lv DJ; Yu YZ; Wang C; Xie T; Wang T; Song XL; Zhao SC
Front Cell Dev Biol; 2021; 9():678967. PubMed ID: 34249931
[TBL] [Abstract][Full Text] [Related]
9. Astragalus-Scorpion Drug Pair Inhibits the Development of Prostate Cancer by Regulating GDPD4-2/PI3K/AKT/mTOR Pathway and Autophagy.
You X; Wu Y; Li Q; Sheng W; Zhou Q; Fu W
Front Pharmacol; 2022; 13():895696. PubMed ID: 35847007
[No Abstract] [Full Text] [Related]
10. Muscleblind-like 1 antisense RNA 1 inhibits cell proliferation, invasion, and migration of prostate cancer by sponging miR-181a-5p and regulating PTEN/PI3K/AKT/mTOR signaling.
Ding X; Xu X; He XF; Yuan Y; Chen C; Shen XY; Su S; Chen Z; Xu ST; Huang YH
Bioengineered; 2021 Dec; 12(1):803-814. PubMed ID: 33648424
[TBL] [Abstract][Full Text] [Related]
11. SLC4A4 promotes prostate cancer progression in vivo and in vitro via AKT-mediated signalling pathway.
Liu Z; Wang Q; Zhai G; Ke S; Yu X; Guo J
Cancer Cell Int; 2022 Mar; 22(1):127. PubMed ID: 35305629
[TBL] [Abstract][Full Text] [Related]
12. GOLM1 promotes prostate cancer progression through activating PI3K-AKT-mTOR signaling.
Yan G; Ru Y; Wu K; Yan F; Wang Q; Wang J; Pan T; Zhang M; Han H; Li X; Zou L
Prostate; 2018 Feb; 78(3):166-177. PubMed ID: 29181846
[TBL] [Abstract][Full Text] [Related]
13. The molecular mechanism of baicalein repressing progression of gastric cancer mediating miR-7/FAK/AKT signaling pathway.
Qiao D; Xing J; Duan Y; Wang S; Yao G; Zhang S; Jin J; Lin Z; Chen L; Piao Y
Phytomedicine; 2022 Jun; 100():154046. PubMed ID: 35306368
[TBL] [Abstract][Full Text] [Related]
14. Scutellaria barbata D.Don (SBD) extracts suppressed tumor growth, metastasis and angiogenesis in Prostate cancer via PI3K/Akt pathway.
Sheng D; Zhao B; Zhu W; Wang T; Peng Y
BMC Complement Med Ther; 2022 May; 22(1):120. PubMed ID: 35505400
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding DANCR targets miR-185-5p to upregulate LIM and SH3 protein 1 promoting prostate cancer via the FAK/PI3K/AKT/GSK3β/snail pathway.
Sun W; Zu S; Shao G; Wang W; Gong F
J Gene Med; 2021 Jul; 23(7):e3344. PubMed ID: 33885171
[TBL] [Abstract][Full Text] [Related]
16. Exploring the Pharmacological Mechanisms of Xihuang Pills Against Prostate Cancer
Wu Y; You X; Lin Q; Xiong W; Guo Y; Huang Z; Dai X; Chen Z; Mei S; Long Y; Tian X; Zhou Q
Front Pharmacol; 2021; 12():791269. PubMed ID: 35342388
[No Abstract] [Full Text] [Related]
17. Downregulation of miR-133a-3p promotes prostate cancer bone metastasis via activating PI3K/AKT signaling.
Tang Y; Pan J; Huang S; Peng X; Zou X; Luo Y; Ren D; Zhang X; Li R; He P; Wa Q
J Exp Clin Cancer Res; 2018 Jul; 37(1):160. PubMed ID: 30021600
[TBL] [Abstract][Full Text] [Related]
18. 14, 15-EET induces breast cancer cell EMT and cisplatin resistance by up-regulating integrin αvβ3 and activating FAK/PI3K/AKT signaling.
Luo J; Yao JF; Deng XF; Zheng XD; Jia M; Wang YQ; Huang Y; Zhu JH
J Exp Clin Cancer Res; 2018 Feb; 37(1):23. PubMed ID: 29426357
[TBL] [Abstract][Full Text] [Related]
19. Long non-coding RNA AC245100.4 activates the PI3K/AKT pathway to promote PCa cell proliferation by elevating PAR2.
Zhang K; Liu C; Hu C; Lin P; Qi Q; Jia H; Tang J; Yu X
Heliyon; 2023 Jun; 9(6):e16870. PubMed ID: 37346322
[TBL] [Abstract][Full Text] [Related]
20. CDT1 facilitates metastasis in prostate cancer and correlates with cell cycle regulation.
Wang C; Che J; Jiang Y; Chen P; Bao G; Li C
Cancer Biomark; 2022; 34(3):459-469. PubMed ID: 35253732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
